Researchers at Massachusetts General Hospital developed and validated a TB risk scoring tool called "TB or Not TB," integrated into the electronic health record, to help clinicians safely and efficiently decide when to discontinue isolation precautions for patients with suspected tuberculosis.
Australian cancer researchers have achieved a breakthrough by establishing a next-generation gene-editing tool using Cas12a, a novel genome-engineering enzyme, to model and interrogate human diseases, including cancer.
Researchers from Dana-Farber Cancer Institute, The Broad Institute, Google, and Columbia University have developed EpiBERT, an AI model that predicts gene expression across human cell types by learning the relationship between DNA sequence and chromatin accessibility.
A new study presented at the Society for Maternal-Fetal Medicine's annual meeting found that AI-based software significantly improved clinicians' ability to detect congenital heart defects in routine prenatal ultrasounds, regardless of the physician's experience level or subspecialty training.
A recent study published in the Canadian Medical Association Journal explores the wide-ranging health benefits of physical activity for older adults, highlighting how exercise reduces mortality, improves cognitive function, and enhances quality of life — yet remains widely underprescribed in clinical care.
A clinical trial testing muvalaplin, a novel oral medication, demonstrated safe and effective reduction of high lipoprotein(a) levels by up to 85.5%, according to late-breaking science presented at the American Heart Association's Scientific Sessions 2024.